[1] Aquino PF, Fischer JS, Neves-Ferreira AG,et al. Are gastric cancer resection margin proteomic profiles more similar to those from control or tumors[J].J Protemoe Res,2012,11:5836-5842. [2] Yang Yongxia, Liang Minfeng, Chen Ali,et al. Principal component analysis applied in the metabonomic studies of serum obtained from esophageal carcinoma patients[J].China Medical Herald,2010,7(23):37-38. [3] 唐磊.国际抗癌联盟及美国癌症联合会胃癌TNM分期系统(第8版)影像相关更新解读[J].中华放射学杂志,2017,51(8):636-637. [4] Murakami H,Ito S,Tanaka H,et al.Establishment of new intraperitoneal Paclitaxe-resistant gastric cancer cell lines and comprehensive gene expression analysis[J].Anticancer Res,2013,33:4299-4307. [5] Liu Y, Xing R, Zhang X, et al.miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells[J].DNA Repair (Amst),2013,12(9):741-750. [6] Li X, Zhang Z, Yu M, et al.Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2)[J].Int J Mol Sci,2013, 6;14(8):16226-16239. [7] Liu J.Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K[J].Int J Oncol,2014,45(1):282-290. [8] Liu H, Li P, Li B,et al. RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN[J].Tumour Biol,2014 ,35(12):11949-11958. [9] 杨洪云,王静. 血清CK18、CEA、CA19-9在胃癌诊断中的临床意义[J].泰山医学院学报,2015,36(04):376-378.
2019, Vol. 36 
